DE69838298T2 - Kontrolle der immunantworten durch regulierung der aktivität von glykosyltransferasen - Google Patents
Kontrolle der immunantworten durch regulierung der aktivität von glykosyltransferasen Download PDFInfo
- Publication number
- DE69838298T2 DE69838298T2 DE69838298T DE69838298T DE69838298T2 DE 69838298 T2 DE69838298 T2 DE 69838298T2 DE 69838298 T DE69838298 T DE 69838298T DE 69838298 T DE69838298 T DE 69838298T DE 69838298 T2 DE69838298 T2 DE 69838298T2
- Authority
- DE
- Germany
- Prior art keywords
- cells
- sialyltransferase
- st6gal
- use according
- analog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1081—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Environmental Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4830397P | 1997-05-30 | 1997-05-30 | |
| US48303P | 1997-05-30 | ||
| PCT/US1998/011260 WO1998054365A1 (en) | 1997-05-30 | 1998-05-29 | Control of immune responses by modulating activity of glycosyltransferases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69838298D1 DE69838298D1 (de) | 2007-10-04 |
| DE69838298T2 true DE69838298T2 (de) | 2008-05-15 |
Family
ID=21953820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69838298T Expired - Lifetime DE69838298T2 (de) | 1997-05-30 | 1998-05-29 | Kontrolle der immunantworten durch regulierung der aktivität von glykosyltransferasen |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US6376475B1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1017846B1 (cg-RX-API-DMAC10.html) |
| JP (2) | JP4451933B2 (cg-RX-API-DMAC10.html) |
| AT (1) | ATE371041T1 (cg-RX-API-DMAC10.html) |
| AU (1) | AU7717598A (cg-RX-API-DMAC10.html) |
| DE (1) | DE69838298T2 (cg-RX-API-DMAC10.html) |
| WO (1) | WO1998054365A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7834800A (en) * | 1999-09-30 | 2001-04-30 | Regents Of The University Of California, The | Prevention of atherosclerosis and undesired blood clotting by reducing von willebrand factor |
| US7192914B1 (en) | 1999-09-30 | 2007-03-20 | The Regents Of The University Of California | Prevention of atherosclerosis and undesired blood clotting by reducing von Willebrand factor |
| US20060210558A1 (en) * | 2000-10-18 | 2006-09-21 | Robert Sackstein | Hematopoietic cell selectin ligand polypeptides and methods of use thereof |
| ES2338757T3 (es) | 2000-10-18 | 2010-05-12 | The Brigham And Women's Hospital, Inc. | Polipeptidos ligandos para selectina-e/selectina-l de la celula hematopoyetica y metodos de utilizacion de los mismos. |
| AU2002327097B2 (en) * | 2001-08-16 | 2007-05-24 | Japan As Represented By President Of National Centre Of Neurology And Psychiatry | Novel glycolipid and remedial agent for autoimmune disease containing the same as active ingredient |
| US20060074047A1 (en) * | 2004-10-06 | 2006-04-06 | Cross Alan S | Method of treating inflammation with inhibitors of sialyl transferases |
| JP4359779B2 (ja) * | 2006-01-23 | 2009-11-04 | ソニー株式会社 | 音響再生装置および音響再生方法 |
| GB0614947D0 (en) * | 2006-07-27 | 2006-09-06 | Isis Innovation | Epitope reduction therapy |
| PL2282773T3 (pl) | 2008-05-02 | 2014-08-29 | Seattle Genetics Inc | Sposoby i kompozycje do wytwarzania przeciwciał i pochodnych przeciwciał o obniżonej fukozylacji rdzeniowej |
| EP3513794A3 (en) | 2010-08-05 | 2019-10-16 | Seattle Genetics, Inc. | Fucose analogs for inhibition of protein fucosylation in vivo |
| JP6334169B2 (ja) * | 2010-12-16 | 2018-05-30 | ビーエーエスエフ アグロ ベー.ブイ. | 除草剤耐性の増大した植物 |
| JP2014159374A (ja) * | 2011-05-20 | 2014-09-04 | Nippon Nohyaku Co Ltd | 作物の枯凋落葉剤組成物 |
| AR091489A1 (es) * | 2012-06-19 | 2015-02-11 | Basf Se | Plantas que tienen una mayor tolerancia a herbicidas inhibidores de la protoporfirinogeno oxidasa (ppo) |
| EP2887947B1 (en) | 2012-08-23 | 2019-06-05 | Seattle Genetics, Inc. | Fucose analogues for the treatment of sickle cell disease |
| JP2016027002A (ja) * | 2012-11-16 | 2016-02-18 | 日本農薬株式会社 | 除草剤組成物 |
| JP6172687B2 (ja) | 2013-05-02 | 2017-08-02 | 国立研究開発法人産業技術総合研究所 | シアリル化糖鎖を認識するモノクローナル抗体 |
| US10285976B2 (en) | 2013-08-12 | 2019-05-14 | The Board Of Trustees Of The Leland Stanford Junior University | 4-methylumbelliferone treatment for immune modulation |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5352462A (en) * | 1982-06-03 | 1994-10-04 | Stolle Research & Development Corporation | Anti-inflammatory factor, method of isolation, and use |
| US5288854A (en) * | 1990-11-28 | 1994-02-22 | Center For Blood Research, Inc. | Functional derivatives of ICAM-1 which are substantially capable of binding to LFA-1 but are substantially incapable of binding to MAC-1 |
| US5461143A (en) * | 1991-03-18 | 1995-10-24 | The Scripps Research Institute | Oligosaccharide enzyme substrates and inhibitors: methods and compositions |
| JPH05247078A (ja) | 1992-03-03 | 1993-09-24 | Japan Tobacco Inc | 糖化合物、シアル酸含有糖鎖類生合成阻害剤、その製造方法、並びに新規な中間体 |
| US5453272A (en) | 1992-10-02 | 1995-09-26 | Alberta Research Council | Lectin derived carbohydrate binding-peptide |
| JPH10504707A (ja) | 1994-06-15 | 1998-05-12 | アレクション・ファーマシューティカル・インク | 異種移植片の超急性拒否反応を減少させる方法 |
| US20040038923A1 (en) * | 2000-10-06 | 2004-02-26 | Marth Jamey D. | Blocking inflammation by inhibiting sialylation |
-
1996
- 1996-12-27 JP JP52994198A patent/JP4451933B2/ja not_active Expired - Fee Related
-
1998
- 1998-05-29 AT AT98925161T patent/ATE371041T1/de not_active IP Right Cessation
- 1998-05-29 US US09/087,117 patent/US6376475B1/en not_active Expired - Lifetime
- 1998-05-29 EP EP98925161A patent/EP1017846B1/en not_active Expired - Lifetime
- 1998-05-29 AU AU77175/98A patent/AU7717598A/en not_active Abandoned
- 1998-05-29 WO PCT/US1998/011260 patent/WO1998054365A1/en not_active Ceased
- 1998-05-29 DE DE69838298T patent/DE69838298T2/de not_active Expired - Lifetime
- 1998-05-29 JP JP50102499A patent/JP2002528037A/ja not_active Ceased
-
2002
- 2002-04-23 US US10/131,721 patent/US20030013636A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US6376475B1 (en) | 2002-04-23 |
| WO1998054365A1 (en) | 1998-12-03 |
| JP2002528037A (ja) | 2002-08-27 |
| EP1017846B1 (en) | 2007-08-22 |
| EP1017846A1 (en) | 2000-07-12 |
| JP2002528036A (ja) | 2002-08-27 |
| US20030013636A1 (en) | 2003-01-16 |
| ATE371041T1 (de) | 2007-09-15 |
| EP1017846A4 (en) | 2004-08-11 |
| DE69838298D1 (de) | 2007-10-04 |
| JP4451933B2 (ja) | 2010-04-14 |
| AU7717598A (en) | 1998-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | A novel aminophospholipid transporter exclusively expressed in spermatozoa is required for membrane lipid asymmetry and normal fertilization | |
| Smith et al. | Conditional control of selectin ligand expression and global fucosylation events in mice with a targeted mutation at the FX locus | |
| US6331658B1 (en) | Genetically engineered mammals for use as organ donors | |
| EP1017846B1 (en) | Control of immune responses by modulating activity of glycosyltransferases | |
| DE69534227T2 (de) | Stoffe und verfahren zur beherrschung der hyperakuten abstossung von menschlichen transplantaten | |
| KR102652838B1 (ko) | Mhc 부류 i 및 부류 ii가 결여된 nsg 마우스 | |
| US7166278B2 (en) | Modified organs and cells for xenotransplantation | |
| Wang et al. | Mice with a homozygous deletion of the Mgat2 gene encoding UDP-N-acetylglucosamine: α-6-D-mannoside β1, 2-N-acetylglucosaminyltransferase II: A model for congenital disorder of glycosylation type IIa | |
| US20040038923A1 (en) | Blocking inflammation by inhibiting sialylation | |
| Bessler et al. | Paroxysmal nocturnal hemoglobinuria: insights from recent advances in molecular biology | |
| Kuan et al. | Multiple phenotypic changes in mice after knockout of the B3gnt5 gene, encoding Lc3 synthase—a key enzyme in lacto-neolacto ganglioside synthesis | |
| Hennet et al. | The remodeling of glycoconjugates in mice | |
| Ikematsu et al. | Transgenic mouse lines with ectopic expression of α-1, 3-galactosyltransferase: production and characteristics | |
| JP2002530425A (ja) | 炎症を処置する際のコア2GlcNAcトランスフェラーゼインヒビターの使用 | |
| US7192914B1 (en) | Prevention of atherosclerosis and undesired blood clotting by reducing von Willebrand factor | |
| US7674577B2 (en) | Diagnosis of human glycosylation disorders | |
| Ohtsubo | Targeted genetic inactivation of N-acetylglucosaminyltransferase-IVa impairs insulin secretion from pancreatic β cells and evokes type 2 diabetes | |
| US7256171B1 (en) | Use of core 2 G1cNAc transferase inhibitors in treating inflammation | |
| US7273711B1 (en) | Diagnosis of human glycosylation disorders | |
| US20080031821A1 (en) | USE OF CORE 2 GlcNAc TRANSFERASE INHIBITORS IN TREATING INFLAMMATION | |
| US20080227689A1 (en) | Dampening Humoral and Innate Immunity by Inhibition of Ppgalnact-1 | |
| US20070142319A1 (en) | Anxiolytic treatment by inhibition of a polysialyltransferase | |
| WO2004006939A1 (en) | Blocking inflammation by inhibiting st3-gal-vi activity | |
| Lu | Defective pituitary function and gamete interactions in beta-1, 4-galactosyltransferase null mice | |
| WO2001022921A2 (en) | Prevention of atherosclerosis and undesired blood clotting by reducing von willebrand factor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |